Pathology
Main Filters
Pathology
| IMMUNALYSIS CORP | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| ASR-A-303-100 | 0 | - | ||
| ASR-A-303-1000 | 0 | - | ||
| ASR-A-308-1000 | 0 | - | ||
| ASR-A-309-100 | 0 | - | ||
| ASR-A-309-1000 | 0 | - | ||
| ASR-A-310-100 | 0 | - | ||
| ASR-A-311-100 | 0 | - | ||
| ASR-A-311-1000 | 0 | - | ||
| ASR-A-312-100 | 0 | - | ||
| ASR-A-312-1000 | 0 | - | ||
| ASR-A-314-100 | 0 | - | ||
| ASR-A-314-1000 | 0 | - | ||
| ASR-A-321-100 | 0 | - | ||
| ASR-A-321-1000 | 0 | - | ||
| ASR-A-336-100 | 0 | - | ||
| ASR-A-336-1000 | 0 | - | ||
| ASR-A-344-100 | 0 | - | ||
| ASR-A-344-1000 | 0 | - | ||
| ASR-E-307-60 | 0 | - | ||
| ASR-E-307-600 | 0 | - | ||
| ASR-E-308-60 | 0 | - | ||
| ASR-E-308-600 | 0 | - | ||
| ASR-E-309-60 | 0 | - | ||
| ASR-E-309-600 | 0 | - | ||
| ASR-E-311-60 | 0 | - | ||
| ASR-E-311-600 | 0 | - | ||
| ASR-E-312-60 | 0 | - | ||
| ASR-E-312-600 | 0 | - | ||
| ASR-E-314-60 | 0 | - | ||
| ASR-E-314-600 | 0 | - | ||
| ASR-E-321-60 | 0 | - | ||
| ASR-E-321-600 | 0 | - | ||
| ASR-E-336-100 | 0 | - | ||
| ASR-E-336-1000 | 0 | - | ||
| ASR-E-344-70 | 0 | - | ||
| ASR-E-344-700 | 0 | - | ||
| GPR-A-178-100 | 0 | - | ||
| GPR-A-178-1000 | 0 | - | ||
| GPR-A-182-100 | 0 | - | ||
| GPR-A-182-1000 | 0 | - | ||
| GPR-A-184-1000 | 0 | - | ||
| GPR-E-180-60 | 0 | - | ||
| GPR-E-180-600 | 0 | - | ||
| GPR-E-180-70 | 0 | - | ||
| GPR-E-180-700 | 0 | - | ||
| GPR-E-181-100 | 0 | - | ||
| GPR-E-181-1000 | 0 | - | ||
| GPR-E-183-60 | 0 | - | ||
| GPR-E-183-600 | 0 | - | ||
| IMMUNALYSIS CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| GPR-A-184-100 | 0 | - | ||
18,184 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Immunalysis Corporation
IMMUNALYSIS CORPORATION
Immunalysis Corporation Antibody Diluent DF with Low NAD & G6P 2X NAD & G6P (100 mL)
0
-
Immunalysis
IMMUNALYSIS CORP
K2 (Synthetic Cannabinoids-1) Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
K2 (Synthetic Cannabinoids-1) Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Buprenorphine Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Buprenorphine Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Benzodiazepines Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Benzodiazepines Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Cocaine/Benzoylecgonine Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Cocaine/Benzoylecgonine Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Methamphetamine Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Amphetamine Enzyme Conjugate Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Amphetamine Enzyme Conjugate Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
PCP Enzyme Conjugate Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Opiates Enzyme Conjugate Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
K2 (Synthetic Cannabinoids-1) Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
K2 (Synthetic Cannabinoids-1) Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Cocaine/Benzoylecgonine Antibody Analyte Specific Reagent (ASR)
0
-
Immunalysis
IMMUNALYSIS CORP
Cocaine/Benzoylecgonine Antibody Analyte Specific Reagent (ASR)